An observational study in Renal Cyst, sponsored by Shanghai Zhongshan Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by Shanghai Zhongshan Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This retrospective study combine radiomics and deep learning models to predict malignancy in Bosniak II-III cystic renal masses, aiming for improving preoperative risk assessment and reducing unnecessary surgery for benign lesions and avoiding delayed treatment of malignant disease.
The main question it aims to answer is:
Patients diagnosed with Bosniak II-III cystic renal masses based on preoperative contrast-enhanced CT were included. The exclusion criteria were solid portion > 25%, polycystic kidney disease, maximum diameter\<1cm, Von Hippel-Lindau syndrome, without complete CT examination or histopathology-proven CRMs, poor image quality and Bosniak I and Bosniak IV masses. Deep learning models were developed to classify renal cystic lesions as benign or malignant using multiphase CT images. The performance measure were the area under the receiver operating characteristic curve, sensitivity, specificity, and balanced accuracy.
Shanghai Zhongshan Hospital is the lead sponsor of 652 studies on the registry; 291 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population includes patients diagnosed with renal cyst in the participated centers. Clinical and imaging data were retrospectively collected from medical records, including demographic characteristics (age, gender, BMI), cyst characters(size, loction, aterality, number of septa, septal thickness, wall thickness, presence of calcification, enhancement pattern, mural nodules, and Bosniak classification). Histopathological findings were also collected when available and were used as the reference standard for lesions that underwent surgical resection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who were istopathologically diagnosed benign renal cysts
Patients who were istopathologically diagnosed malignant renal cysts
the area under the receiver operating characteristic curve
The area under the receiver operating characteristic curve measures the overall ability of a binary classifier to distinguish between positive and negative classes, with values ranging from 0.5 (random guessing) to 1.0 (perfect classification).
Time frame: preoperatively
sensitivity
Sensitivity measures the proportion of actual positive cases that are correctly identified by the model. A higher sensitivity indicates that the model is better at detecting positive cases and produces fewer false negatives.
Time frame: preoperatively
specificity
Specificity measures the proportion of actual negative cases that are correctly identified by the model. A higher specificity indicates that the model is better at correctly excluding negative cases and produces fewer false positives.
Time frame: preoperatively
balanced accuracy
Balanced accuracy is the average of sensitivity and specificity. It provides an overall measure of classification performance while giving equal importance to the positive and negative classes, making it particularly useful when the classes are imbalanced.
Time frame: preoperatively
Plan to share: Yes — Clinical data and extracted radiomics feature data, excluding patient information.
Supporting information: Study protocol
Time frame: Within six months after publication in the journal.
Access criteria: The data supporting this study are available from the enrolled institutions, but restrictions apply to their availability due to privacy reasons. Data can be accessed upon reasonable request from the corresponding author.
No publications or documents are linked to this record.
Ran from Sep 2024 to primary completion in Dec 2024, 3 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kidney Diseases, Cystic